Small variant surface antigens and Plasmodium evasion of immunity

Future Microbiology

Volumn 5, Issue 4, 2010, Pages 663-682

  Jemmely, Noelle Yvonne ^a   Niang, Makhtar ^a   Preiser, Peter Rainer ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Variant surface antigens

Indexed keywords

VARIANT SURFACE GLYCOPROTEIN;

ANTIGENIC VARIATION; ERYTHROCYTE; ERYTHROCYTE ADHESIVENESS; GENE EXPRESSION REGULATION; HOST PARASITE INTERACTION; HUMAN; IMMUNE EVASION; MALARIA; MULTIGENE FAMILY; NONHUMAN; PARASITE IMMUNITY; PLASMODIUM; PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; PLASMODIUM KNOWLESI; PLASMODIUM VIVAX; PLASMODIUM YOELII; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTOZOAL GENETICS; REVIEW; ROSETTE FORMATION;

ANIMALS; ANTIGENIC VARIATION; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; HUMANS; IMMUNE EVASION; IMMUNITY; MALARIA; PLASMODIUM;

PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; PLASMODIUM KNOWLESI; PLASMODIUM VIVAX; PLASMODIUM YOELII; RODENTIA;

EID: 77950466510     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.10.21     Document Type: Review

References (160)

1. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI: The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434(7030), 214-217 (2005).
2. Kirk K: Channels and transporters as drug targets in the Plasmodium-infected erythrocyte. Acta Trop. 89(3), 285-298 (2004).
3. Craig A, Scherf A: Molecules on the surface of the Plasmodium falciparum infected erythrocyte and their role in malaria pathogenesis and immune evasion. Mol. Biochem. Parasitol. 115(2), 129-143 (2001).
4. Saul A: The role of variant surface antigens on malaria-infected red blood cells. Parasitol. Today 15(11), 455-457 (1999).
5. Miller LH, Baruch DI, Marsh K, Doumbo OK: The pathogenic basis of malaria. Nature 415(6872), 673-679 (2002).
6. Beeson JG, Brown GV: Pathogenesis of Plasmodium falciparum malaria: the roles of parasite adhesion and antigenic variation. Cell Mol. Life Sci. 59(2), 258-271 (2002).
7. Fried M, Duffy PE: Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 272(5267), 1502-1504 (1996).
8. Rogerson SJ, Brown GV: Chondroitin sulphate A as an adherence receptor for Plasmodium falciparum-infected erythrocytes. Parasitol. Today 13(2), 70-75 (1997).
9. Heddini A, Pettersson F, Kai O et al.: Fresh isolates from children with severe Plasmodium falciparum malaria bind to multiple receptors. Infect. Immun. 69(9), 5849-5856 (2001).
10. Angus BJ, Thanikkul K, Silamut K, White NJ, Udomsangpetch R: Short report: Rosette formation in Plasmodium ovale infection. Am. J. Trop. Med. Hyg. 55(5), 560-561 (1996).
11. Chotivanich KT, Pukrittayakamee S, Simpson JA, White NJ, Udomsangpetch R: Characteristics of Plasmodium vivax-infected erythrocyte rosettes. Am. J. Trop. Med. Hyg. 59(1), 73-76 (1998).
12. David PH, Handunnetti SM, Leech JH, Gamage P, Mendis KN: Rosetting: a new cytoadherence property of malaria-infected erythrocytes. Am. J. Trop. Med. Hyg. 38(2), 289-297 (1988).
13. Mackinnon MJ, Walker PR, Rowe JA: Plasmodium chabaudi: rosetting in a rodent malaria model. Exp. Parasitol. 101(2-3), 121-128 (2002).
14. Udomsangpetch R, Brown AE, Smith CD, Webster HK: Rosette formation by Plasmodium coatneyi-infected red blood cells. Am. J. Trop. Med. Hyg. 44(4), 399-401 (1991).
15. Staalsoe T, Nielsen MA, Vestergaard LS, Jensen AT, Theander TG, Hviid L: In vitro selection of Plasmodium falciparum 3D7 for expression of variant surface antigens associated with severe malaria in African children. Parasite Immunol. 25(8-9), 421-427 (2003).
16. Gardner MJ, Hall N, Fung E et al.: Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419(6906), 498-511 (2002).
17. Bull PC, Marsh K: The role of antibodies to Plasmodium falciparum-infected-erythrocyte surface antigens in naturally acquired immunity to malaria. Trends Microbiol. 10(2), 55-58 (2002).
18. Udeinya IJ, Schmidt JA, Aikawa M, Miller LH, Green I: Falciparum malaria-infected erythrocytes specifically bind to cultured human endothelial cells. Science 213(4507), 555-557 (1981).
19. Udomsangpetch R, Wahlin B, Carlson J et al.: Plasmodium falciparum-infected erythrocytes form spontaneous erythrocyte rosettes. J. Exp. Med. 169(5), 1835-1840 (1989). (Pubitemid 19126838)
20. Borst P, Bitter W, McCulloch R, Van Leeuwen F, Rudenko G: Antigenic variation in malaria. Cell 82(1), 1-4 (1995).
21. Ferreira MU, da Silva Nunes M, Wunderlich G: Antigenic diversity and immune evasion by malaria parasites. Clin. Diagn. Lab. Immunol. 11(6), 987-995 (2004).
22. Flick K, Chen Q: var genes, PfEMP1 and the human host. Mol. Biochem. Parasitol. 134(1), 3-9 (2004).
23. Scherf A, Lopez-Rubio JJ, Riviere L: Antigenic variation in Plasmodium falciparum. Annu. Rev. Microbiol. 62, 445-470 (2008).
24. al-Khedery B, Barnwell JW, Galinski MR: Antigenic variation in malaria: a 3́ genomic alteration associated with the expression of a P. knowlesi variant antigen. Mol. Cell 3(2), 131-141 (1999).
25. Brown KN, Brown IN: Immunity to malaria: antigenic variation in chronic infections of Plasmodium knowlesi. Nature 208(5017), 1286-1288 (1965).
26. del Portillo HA, Fernandez-Becerra C, Bowman S et al.: A superfamily of variant genes encoded in the subtelomeric region of Plasmodium vivax. Nature 410(6830), 839-842 (2001).
27. Janssen CS, Barrett MP, Turner CM, Phillips RS: A large gene family for putative variant antigens shared by human and rodent malaria parasites. Proc. Biol. Sci. 269(1489), 431-436 (2002).
28. Cox HW: A study of relapse Plasmodium berghei infections isolated from white mice. J. Immunol. 82(3), 209-214 (1959).
29. Cox HW: The behaviour of Plasmodium berghei strains isolated from relapsed infections of white mice. J. Protozool. 9, 114-118 (1962).
30. Eaton MD: The agglutination of Plasmodium knowlesi by immune serum. J. Exp. Med. 67(6), 857-870 (1938).
31. Brown KN: Antibody induced variation in malaria parasites. Nature 242(5392), 49-50 (1973).
32. Brown KN, Hills LA: Antigenic variation and immunity to Plasmodium knowlesi: antibodies which induce antigenic variation and antibodies which destroy parasites. Trans. R. Soc. Trop. Med. Hyg. 68(2), 139-142 (1974).
33. Barnwell JW, Howard RJ, Coon HG, Miller LH: Splenic requirement for antigenic variation and expression of the variant antigen on the erythrocyte membrane in cloned Plasmodium knowlesi malaria. Infect. Immun. 40(3), 985-994 (1983).
34. Marsh K, Howard RJ: Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. Science 231(4734), 150-153 (1986).
35. Marsh K, Otoo L, Hayes RJ, Carson DC, Greenwood BM: Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans. R. Soc. Trop. Med. Hyg. 83(3), 293-303 (1989).
36. Howard RJ, Barnwell JW, Kao V: Antigenic variation of Plasmodium knowlesi malaria: identification of the variant antigen on infected erythrocytes. Proc. Natl Acad. Sci. USA 80(13), 4129-4133 (1983).
37. Baruch DI, Pasloske BL, Singh HB et al.: Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 82(1), 77-87 (1995).
38. Smith JD, Chitnis CE, Craig AG et al.: Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 82(1), 101-110 (1995).
39. Su XZ, Heatwole VM, Wertheimer SP et al.: The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell 82(1), 89-100 (1995).
40. Rowe JA, Moulds JM, Newbold CI, Miller LH: P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 388(6639), 292-295 (1997).
41. Korir CC, Galinski MR: Proteomic studies of Plasmodium knowlesi SICA variant antigens demonstrate their relationship with P. falciparum EMP1. Infect. Genet. Evol. 6(1), 75-79 (2006).
42. Newbold CI, Pinches R, Roberts DJ, Marsh K: Plasmodium falciparum: the human agglutinating antibody response to the infected red cell surface is predominantly variant specific. Exp. Parasitol. 75(3), 281-292 (1992).
43. Sherman IW, Eda S, Winograd E: Cytoadherence and sequestration in Plasmodium falciparum: defining the ties that bind. Microbes Infect. 5(10), 897-909 (2003). (Pubitemid 36959939)
44. Barnwell JW, Howard RJ, Miller LH: Influence of the spleen on the expression of surface antigens on parasitized erythrocytes. Ciba Found. Symp. 94, 117-136 (1983).
45. Handunnetti SM, Mendis KN, David PH: Antigenic variation of cloned Plasmodium fragile in its natural host Macaca sinica. Sequential appearance of successive variant antigenic types. J. Exp. Med. 165(5), 1269-1283 (1987).
46. Israeli A, Shapiro M, Ephros MA: Plasmodium falciparum malaria in an asplenic man. Trans. R. Soc. Trop. Med. Hyg. 81(2), 233-234 (1987).
47. Looareesuwan S, Suntharasamai P, Webster HK, Ho M: Malaria in splenectomized patients: report of four cases and review. Clin. Infect. Dis. 16(3), 361-366 (1993). (Pubitemid 23066942)
48. Bachmann A, Esser C, Petter M et al.: Absence of erythrocyte sequestration and lack of multicopy gene family expression in Plasmodium falciparum from a splenectomized malaria patient. PLoS ONE 4(10), e7459 (2009).
49. Rowe A, Obeiro J, Newbold CI, Marsh K: Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect. Immun. 63(6), 2323-2326 (1995).
50. Rowe JA, Obiero J, Marsh K, Raza A: Short report: Positive correlation between rosetting and parasitemia in Plasmodium falciparum clinical isolates. Am. J. Trop. Med. Hyg. 66(5), 458-460 (2002).
51. Carlson J, Helmby H, Hill AV, Brewster D, Greenwood BM, Wahlgren M: Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 336(8729), 1457-1460 (1990).
52. Clough B, Atilola FA, Pasvoi G: The role of rosetting in the multiplication of Plasmodium falciparum: rosette formation neither enhances nor targets parasite invasion into uninfected red cells. Br. J. Haematol. 100(1), 99-104 (1998). (Pubitemid 28051846)
53. Mackintosh CL, Beeson JG, Marsh K: Clinical features and pathogenesis of severe malaria. Trends Parasitol. 20(12), 597-603 (2004). (Pubitemid 39446751)
54. Kaul DK, Roth EF Jr, Nagel RL, Howard RJ, Handunnetti SM: Rosetting of Plasmodium falciparum-infected red blood cells with uninfected red blood cells enhances microvascular obstruction under flow conditions. Blood 78(3), 812-819 (1991).
55. Vogt AM, Barragan A, Chen Q, Kironde F, Spillmann D, Wahlgren M: Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1a domain of PfEMP1. Blood 101(6), 2405-2411 (2003). (Pubitemid 36302089)
56. Fernandez V, Hommel M, Chen Q, Hagblom P, Wahlgren M: Small, clonally variant antigens expressed on the surface of the Plasmodium falciparum-infected erythrocyte are encoded by the rif gene family and are the target of human immune responses. J. Exp. Med. 190(10), 1393-1404 (1999).
57. Kyes SA, Rowe JA, Kriek N, Newbold CI: Rifins: a second family of clonally variant proteins expressed on the surface of red cells infected with Plasmodium falciparum. Proc. Natl Acad. Sci. USA 96(16), 9333-9338 (1999). (Pubitemid 29374755)
58. Lavazec C, Sanyal S, Templeton TJ: Hypervariability within the Rifin, Stevor and Pfmc-2TM superfamilies in Plasmodium falciparum. Nucleic Acids Res. 34(22), 6696-6707 (2006). (Pubitemid 46017961)
59. Niang M, Yan Yam X, Preiser PR: The Plasmodium falciparum STEVOR multigene family mediates antigenic variation of the infected erythrocyte. PLoS Pathog. 5(2), e1000307 (2009).
60. Cheng Q, Cloonan N, Fischer K et al.: stevor and rif are Plasmodium falciparum multicopy gene families which potentially encode variant antigens. Mol. Biochem. Parasitol. 97(1-2), 161-176 (1998). (Pubitemid 28558710)
61. Sam-Yellowe TY, Florens L, Johnson JR et al.: A Plasmodium gene family encoding Maurer's cleft membrane proteins: structural properties and expression profiling. Genome Res. 14(6), 1052-1059 (2004).
62. Khattab A, Klinkert MQ: Maurer's clefts-restricted localization, orientation and export of a Plasmodium falciparum RIFIN. Traffic 7(12), 1654-1665 (2006). (Pubitemid 44742368)
63. Marti M, Good RT, Rug M, Knuepfer E, Cowman AF: Targeting malaria virulence and remodeling proteins to the host erythrocyte. Science 306(5703), 1930-1933 (2004). (Pubitemid 39627856)
64. Joannin N, Abhiman S, Sonnhammer EL, Wahlgren M: Sub-grouping and sub-functionalization of the RIFIN multi-copy protein family. BMC Genomics 9, 19 (2008). (Pubitemid 351315030)
65. Petter M, Haeggstrom M, Khattab A, Fernandez V, Klinkert MQ, Wahlgren M: Variant proteins of the Plasmodium falciparum RIFIN family show distinct subcellular localization and developmental expression patterns. Mol. Biochem. Parasitol. 156(1), 51-61 (2007). (Pubitemid 47348143)
66. Bultrini E, Brick K, Mukherjee S et al.: Revisiting the Plasmodium falciparum RIFIN family: from comparative genomics to 3D-model prediction. BMC Genomics 10, 445 (2009).
67. Kyes S, Horrocks P, Newbold C: Antigenic variation at the infected red cell surface in malaria. Annu. Rev. Microbiol. 55, 673-707 (2001). (Pubitemid 32978120)
68. Petter M, Bonow I, Klinkert MQ: Diverse expression patterns of subgroups of the rif multigene family during Plasmodium falciparum gametocytogenesis. PLoS ONE 3(11), e3779 (2008).
69. Florens L, Washburn MP, Raine JD et al.: A proteomic view of the Plasmodium falciparum life cycle. Nature 419(6906), 520-526 (2002).
70. four stages of the parasite life cycle (sporozoites, merozoites, trophozoites and gametocytes).
71. Le Roch KG, Zhou Y, Blair PL et al.: Discovery of gene function by expression profiling of the malaria parasite life cycle. Science 301(5639), 1503-1508 (2003). (Pubitemid 37128535)
72. parasite's life cycle with the aim to assign gene function.
73. Abdel-Latif MS, Dietz K, Issifou S, Kremsner PG, Klinkert MQ: Antibodies to Plasmodium falciparum rifin proteins are associated with rapid parasite clearance and asymptomatic infections. Infect. Immun. 71(11), 6229-6233 (2003). (Pubitemid 37337679)
74. Abdel-Latif MS, Cabrera G, Kohler C, Kremsner PG, Luty AJ: Antibodies to rifin: a component of naturally acquired responses to Plasmodium falciparum variant surface antigens on infected erythrocytes. Am. J. Trop. Med. Hyg. 71(2), 179-186 (2004). (Pubitemid 39108827)
75. Limpaiboon T, Shirley MW, Kemp DJ, Saul A: 7H8/6, a multicopy DNA probe for distinguishing isolates of Plasmodium falciparum. Mol. Biochem. Parasitol. 47(2), 197-206 (1991).
76. Finn RD, Mistry J, Schuster-Bockler B et al.: Pfam: clans, web tools and services. Nucleic Acids Res. 34, D247-D251 (2006).
77. Gardner MJ, Tettelin H, Carucci DJ et al.: Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum. Science 282(5391), 1126-1132 (1998). (Pubitemid 28516242)
78. Kaviratne M, Khan SM, Jarra W, Preiser PR: Small variant STEVOR antigen is uniquely located within Maurer's clefts in Plasmodium falciparum-infected red blood cells. Eukaryot. Cell 1(6), 926-935 (2002). (Pubitemid 36557713)
79. Lavazec C, Sanyal S, Templeton TJ: Expression switching in the stevor and Pfmc-2TM superfamilies in Plasmodium falciparum. Mol. Microbiol. 64(6), 1621-1634 (2007). (Pubitemid 46889912)
80. Blythe JE, Yam XY, Kuss C et al.: Plasmodium falciparum STEVOR proteins are highly expressed in patient isolates and located in the surface membranes of infected red blood cells and the apical tips of merozoites. Infect. Immun. 76(7), 3329-3336 (2008).
81. Templeton TJ: The varieties of gene amplification, diversification and hypervariability in the human malaria parasite, Plasmodium falciparum. Mol. Biochem. Parasitol. 166(2), 109-116 (2009).
82. Khattab A, Bonow I, Schreiber N, Petter M, Schmetz C, Klinkert MQ: Plasmodium falciparum variant STEVOR antigens are expressed in merozoites and possibly associated with erythrocyte invasion. Malar. J. 7, 137 (2008).
83. McRobert L, Preiser P, Sharp S et al.: Distinct trafficking and localization of STEVOR proteins in three stages of the Plasmodium falciparum life cycle. Infect. Immun. 72(11), 6597-6602 (2004). (Pubitemid 39425442)
84. Blythe JE, Niang M, Marsh K, Holder AA, Langhorne J, Preiser PR: Characterization of the repertoire diversity of the Plasmodium falciparum stevor multigene family in laboratory and field isolates. Malar. J. 8, 140 (2009).
85. Schreiber N, Khattab A, Petter M et al.: Expression of Plasmodium falciparum 3D7 STEVOR proteins for evaluation of antibody responses following malaria infections in naive infants. Parasitology 135(2), 155-167 (2008). (Pubitemid 351156583)
86. Epp C, Raskolnikov D, Deitsch KW: A regulatable transgene expression system for cultured Plasmodium falciparum parasites. Malar. J. 7, 86 (2008). (Pubitemid 351793272)
87. Calderwood MS, Gannoun-Zaki L, Wellems TE, Deitsch KW: Plasmodium falciparum var genes are regulated by two regions with separate promoters, one upstream of the coding region and a second within the intron. J. Biol. Chem. 278(36), 34125-34132 (2003).
88. Deitsch KW, Calderwood MS, Wellems TE: Malaria. Cooperative silencing elements in var genes. Nature 412(6850), 875-876 (2001).
89. Dzikowski R, Li F, Amulic B et al.: Mechanisms underlying mutually exclusive expression of virulence genes by malaria parasites. EMBO Rep. 8(10), 959-965 (2007).
90. Frank M, Dzikowski R, Costantini D, Amulic B, Berdougo E, Deitsch K: Strict pairing of var promoters and introns is required for var gene silencing in the malaria parasite Plasmodium falciparum. J. Biol. Chem. 281(15), 9942-9952 (2006).
91. Freitas-Junior LH, Hernandez-Rivas R, Ralph SA et al.: Telomeric heterochromatin propagation and histone acetylation control mutually exclusive expression of antigenic variation genes in malaria parasites. Cell 121(1), 25-36 (2005).
92. Lopez-Rubio JJ, Gontijo AM, Nunes MC, Issar N, Hernandez Rivas R, Scherf A: 5́ flanking region of var genes nucleate histone modification patterns linked to phenotypic inheritance of virulence traits in malaria parasites. Mol. Microbiol. 66(6), 1296-1305 (2007).
93. Lopez-Rubio JJ, Mancio-Silva L, Scherf A: Genome-wide analysis of heterochromatin associates clonally variant gene regulation with perinuclear repressive centers in malaria parasites. Cell Host Microbe 5(2), 179-190 (2009).
94. Tham WH, Payne PD, Brown GV, Rogerson SJ: Identification of basic transcriptional elements required for rif gene transcription. Int. J. Parasitol. 37(6), 605-615 (2007).
95. Cabral FJ, Wunderlich G: Transcriptional memory and switching in the Plasmodium falciparum rif gene family. Mol. Biochem. Parasitol. 168, 186-190 (2009).
96. Sharp S, Lavstsen T, Fivelman QL et al.: Programmed transcription of the var gene family, but not of stevor, in Plasmodium falciparum gametocytes. Eukaryot. Cell 5(8), 1206-1214 (2006).
97. Dzikowski R, Deitsch KW: Active transcription is required for maintenance of epigenetic memory in the malaria parasite Plasmodium falciparum. J. Mol. Biol. 382(2), 288-297 (2008).
98. Iyer JK, Amaladoss A, Genesan S, Preiser PR: Variable expression of the 235 kDa rhoptry protein of Plasmodium yoelii mediate host cell adaptation and immune evasion. Mol. Microbiol. 65(2), 333-346 (2007).
99. Howitt CA, Wilinski D, Llinas M, Templeton TJ, Dzikowski R, Deitsch KW: Clonally variant gene families in Plasmodium falciparum share a common activation factor. Mol. Microbiol. 73(6), 1171-1185 (2009).
100. Sutherland CJ: Stevor transcripts from Plasmodium falciparum gametocytes encode truncated polypeptides. Mol. Biochem. Parasitol. 113(2), 331-335 (2001).
101. Fischer K, Chavchich M, Huestis R, Wilson DW, Kemp DJ, Saul A: Ten families of variant genes encoded in subtelomeric regions of multiple chromosomes of Plasmodium chabaudi, a malaria species that undergoes antigenic variation in the laboratory mouse. Mol. Microbiol. 48(5), 1209-1223 (2003).
102. Janssen CS, Phillips RS, Turner CM, Barrett MP: Plasmodium interspersed repeats: the major multigene superfamily of malaria parasites. Nucleic Acids Res. 32(19), 5712-5720 (2004).
103. Carlton JM, Adams JH, Silva JC et al.: Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 455(7214), 757-763 (2008).
104. Merino EF, Fernandez-Becerra C, Durham AM et al.: Multi-character population study of the vir subtelomeric multigene superfamily of Plasmodium vivax, a major human malaria parasite. Mol. Biochem. Parasitol. 149(1), 10-16 (2006).
105. Winter G, Kawai S, Haeggstrom M et al.: SURFIN is a polymorphic antigen expressed on Plasmodium falciparum merozoites and infected erythrocytes. J. Exp. Med. 201(11), 1853-1863 (2005).
106. Fernandez-Becerra C, Pein O, de Oliveira TR et al.: Variant proteins of Plasmodium vivax are not clonally expressed in natural infections. Mol. Microbiol. 58(3), 648-658 (2005).
107. Bozdech Z, Mok S, Hu G et al.: The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Proc. Natl Acad. Sci. USA 105(42), 16290-16295 (2008).
108. Oliveira TR, Fernandez-Becerra C, Jimenez MC, Del Portillo HA, Soares IS: Evaluation of the acquired immune responses to Plasmodium vivax VIR variant antigens in individuals living in malaria-endemic areas of Brazil. Malar. J. 5, 83 (2006).
109. Carlton JM, Angiuoli SV, Suh BB et al.: Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature 419(6906), 512-519 (2002).
110. Cunningham DA, Jarra W, Koernig S et al.: Host immunity modulates transcriptional changes in a multigene family (yir) of rodent malaria. Mol. Microbiol. 58(3), 636-647 (2005).
111. Fonager J, Cunningham D, Jarra W et al.: Transcription and alternative splicing in the yir multigene family of the malaria parasite Plasmodium y. yoelii: identification of motifs suggesting epigenetic and post-transcriptional control of RNA expression. Mol. Biochem. Parasitol. 156(1), 1-11 (2007).
112. Cunningham D, Fonager J, Jarra W, Carret C, Preiser P, Langhorne J: Rapid changes in transcription profiles of the Plasmodium yoelii yir multigene family in clonal populations: lack of epigenetic memory? PLoS ONE 4(1), e4285 (2009).
113. Hall N, Carlton J: Comparative genomics of malaria parasites. Curr. Opin. Genet. Dev. 15(6), 609-613 (2005).
114. Hall N, Karras M, Raine JD et al.: A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science 307(5706), 82-86 (2005).
115. Di Girolamo F, Raggi C, Birago C et al.: Plasmodium lipid rafts contain proteins implicated in vesicular trafficking and signalling as well as members of the PIR superfamily, potentially implicated in host immune system interactions. Proteomics 8(12), 2500-2513 (2008).
116. Pain A, Bohme U, Berry AE et al.: The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature 455(7214), 799-803 (2008).
117. Oh KI, Kim BK, Ban YL et al.: CD99 activates T cells via a costimulatory function that promotes raft association of TCR complex and tyrosine phosphorylation of TCR z. Exp. Mol. Med. 39(2), 176-184 (2007).
118. Finlay BB, McFadden G: Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 124(4), 767-782 (2006).
119. Brannan LR, Turner CM, Phillips RS: Malaria parasites undergo antigenic variation at high rates in vivo. Proc. Biol. Sci. 256(1345), 71-75 (1994).
120. Hommel M, The role of variant antigens in acquired immunity to Plasmodium falciparum. Ann. Soc. Belg. Med. Trop. 65(Suppl. 2), 57-67 (1985).
121. McLean SA, Pearson CD, Phillips RS: Plasmodium chabaudi: relationship between the occurrence of recrudescent parasitaemias in mice and the effective levels of acquired immunity. Exp. Parasitol. 54(2), 213-221 (1982).
122. McLean SA, Pearson CD, Phillips RS: Plasmodium chabaudi: antigenic variation during recrudescent parasitaemias in mice. Exp. Parasitol. 54(3), 296-302 (1982).
123. Anstey NM, Handojo T, Pain MC et al.: Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. J. Infect. Dis. 195(4), 589-596 (2007).
124. Fujioka H, Millet P, Maeno Y et al.: A nonhuman primate model for human cerebral malaria: rhesus monkeys experimentally infected with Plasmodium fragile. Exp. Parasitol. 78(4), 371-376 (1994).
125. Biggs BA, Gooze L, Wycherley K et al.: Antigenic variation in Plasmodium falciparum. Proc. Natl Acad. Sci. USA 88(20), 9171-9174 (1991).
126. Newbold C, Warn P, Black G et al.: Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am. J. Trop. Med. Hyg. 57(4), 389-398 (1997).
127. Rahman W, Chotivanich K, Silamut K et al.: Plasmodium malariae in Bangladesh. Trans. R. Soc. Trop. Med. Hyg. 104(1), 78-80 (2010).
128. Roberts DJ, Craig AG, Berendt AR et al.: Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 357(6380), 689-692 (1992).
129. Chen Q, Barragan A, Fernandez V et al.: Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum. J. Exp. Med. 187(1), 15-23 (1998).
130. Helmby H, Cavelier L, Pettersson U, Wahlgren M: Rosetting Plasmodium falciparum-infected erythrocytes express unique strain-specific antigens on their surface. Infect. Immun. 61(1), 284-288 (1993).
131. Chen Q, Heddini A, Barragan A, Fernandez V, Pearce SF, Wahlgren M: The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors. J. Exp. Med. 192(1), 1-10 (2000).
132. Baruch DI, Ma XC, Singh HB, Bi X, Pasloske BL, Howard RJ: Identification of a region of PfEMP1 that mediates adherence of Plasmodium falciparum infected erythrocytes to CD36: conserved function with variant sequence. Blood 90(9), 3766-3775 (1997).
133. Howell DP, Levin EA, Springer AL et al.: Mapping a common interaction site used by Plasmodium falciparum Duffy binding-like domains to bind diverse host receptors. Mol. Microbiol. 67(1), 78-87 (2008).
134. Marsh K, Sherwood JA, Howard RJ: Parasite-infected-cell-agglutination and indirect immunofluorescence assays for detection of human serum antibodies bound to antigens on Plasmodium falciparum-infected erythrocytes. J. Immunol. Methods 91(1), 107-115 (1986).
135. Bull PC, Lowe BS, Kortok M, Molyneux CS, Newbold CI, Marsh K: Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat. Med. 4(3), 358-360 (1998).
136. Tourneur N, Scherf A, Wahlgren M, Gysin J: The squirrel monkey as an experimental model for Plasmodium falciparum erythrocyte rosette formation. Am. J. Trop. Med. Hyg. 47(5), 633-642 (1992).
137. Treutiger CJ, Carlson J, Scholander C, Wahlgren M: The time course of cytoadhesion, immunoglobulin binding, rosette formation, and serum-induced agglutination of Plasmodium falciparum-infected erythrocytes. Am. J. Trop. Med. Hyg. 59(2), 202-207 (1998).
138. Treutiger CJ, Hedlund I, Helmby H et al.: Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. Am. J. Trop. Med. Hyg. 46(5), 503-510 (1992).
139. Franke-Fayard B, Janse CJ, Cunha-Rodrigues M et al.: Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc. Natl Acad. Sci. USA 102(32), 11468-11473 (2005).
140. Chotivanich K, Udomsangpetch R, Pukrittayakamee S et al.: The adhesion receptors of P. vivax-infected red cells. Exp. Parasitol. 105, 33-34 (2003).
141. Traore B, Muanza K, Looareesuwan S et al.: Cytoadherence characteristics of Plasmodium falciparum isolates in Thailand using an in vitro human lung endothelial cells model. Am. J. Trop. Med. Hyg. 62(1), 38-44 (2000).
142. Robert C, Pouvelle B, Meyer P et al.: Chondroitin-4-sulphate (proteoglycan), a receptor for Plasmodium falciparum-infected erythrocyte adherence on brain microvascular endothelial cells. Res. Immunol. 146(6), 383-393 (1995).
143. Mendis K, Sina BJ, Marchesini P, Carter R: The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64(1-2 Suppl.), 97-106 (2001).
144. Trager W, Jensen JB: Human malaria parasites in continuous culture. Science 193(4254), 673-675 (1976).
145. Waters AP: Orthology between the genomes of Plasmodium falciparum and rodent malaria parasites: possible practical applications. Philos. Trans. R. Soc. Lond. B Biol. Sci. 357(1417), 55-63 (2002).
146. Cooke BM, Berendt AR, Craig AG, MacGregor J, Newbold CI, Nash GB: Rolling and stationary cytoadhesion of red blood cells parasitized by Plasmodium falciparum: separate roles for ICAM-1, CD36 and thrombospondin. Br. J. Haematol. 87(1), 162-170 (1994).
147. McCormick CJ, Craig A, Roberts D, Newbold CI, Berendt AR: Intercellular adhesion molecule-1 and CD36 synergize to mediate adherence of Plasmodium falciparum-infected erythrocytes to cultured human microvascular endothelial cells. J. Clin. Invest. 100(10), 2521-2529 (1997).
148. Handunnetti SM, van Schravendijk MR, Hasler T, Barnwell JW, Greenwalt DE, Howard RJ: Involvement of CD36 on erythrocytes as a rosetting receptor for Plasmodium falciparum-infected erythrocytes. Blood 80(8), 2097-2104 (1992).
149. Carlson J, Ekre HP, Helmby H, Gysin J, Greenwood BM, Wahlgren M: Disruption of Plasmodium falciparum erythrocyte rosettes by standard heparin and heparin devoid of anticoagulant activity. Am. J. Trop. Med. Hyg. 46(5), 595-602 (1992).
150. Carlson J, Wahlgren M: Plasmodium falciparum erythrocyte rosetting is mediated by promiscuous lectin-like interactions. J. Exp. Med. 176(5), 1311-1317 (1992).
151. Howard RJ, Lyon JA, Diggs CL et al.: Localization of the major Plasmodium falciparum glycoprotein on the surface of mature intraerythrocytic trophozoites and schizonts. Mol. Biochem. Parasitol. 11, 349-362 (1984).
152. Leech JH, Barnwell JW, Aikawa M, Miller LH, Howard RJ: Plasmodium falciparum malaria: association of knobs on the surface of infected erythrocytes with a histidine-rich protein and the erythrocyte skeleton. J. Cell Biol. 98(4), 1256-1264 (1984).
153. Daily JP, Scanfeld D, Pochet N et al.: Distinct physiological states of Plasmodium falciparum in malaria-infected patients. Nature 450(7172), 1091-1095 (2007).
154. Mok BW, Ribacke U, Winter G et al.: Comparative transcriptomal analysis of isogenic Plasmodium falciparum clones of distinct antigenic and adhesive phenotypes. Mol. Biochem. Parasitol. 151(2), 184-192 (2007).
155. Delahaye NF, Coltel N, Puthier D et al.: Gene-expression profiling discriminates between cerebral malaria (CM)-susceptible mice and CM-resistant mice. J. Infect. Dis. 193(2), 312-321 (2006).
156. Lovegrove FE, Pena-Castillo L, Mohammad N, Liles WC, Hughes TR, Kain KC: Simultaneous host and parasite expression profiling identifies tissue-specific transcriptional programs associated with susceptibility or resistance to experimental cerebral malaria. BMC Genomics 7, 295 (2006). (Pubitemid 44873547)
157. Bozdech Z, Llinas M, Pulliam BL, Wong ED, Zhu J, DeRisi JL: The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol. 1(1), E5 (2003).
158. Foth BJ, Zhang N, Mok S, Preiser PR, Bozdech Z: Quantitative protein expression profiling reveals extensive post-transcriptional regulation and post-translational modifications in schizont-stage malaria parasites. Genome Biol. 9(12), R177 (2008).
159. Le Roch KG, Johnson JR, Florens L et al.: Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle. Genome Res. 14(11), 2308-2318 (2004). (Pubitemid 39517338)
160. Handunnetti SM, Gilladoga AD, van Schravendijk MR, Nakamura K, Aikawa M, Howard RJ: Purification and in vitro selection of rosette-positive (R+) and rosette-negative (R-) phenotypes of knob-positive Plasmodium falciparum parasites. Am. J. Trop. Med. Hyg. 46(4), 371-381 (1992).